Covered recipient · General Payments record
LYNZY M DEVARY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$777.07
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $393.85 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $170.10 | 12 |
| Phathom Pharmaceuticals, Inc. | $143.22 | 2 |
| Lilly USA, LLC | $59.01 | 4 |
| ABBVIE INC. | $21.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.52 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107016362 | CMS |
| Lilly USA, LLC | $14.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135742118 | CMS |
| Lilly USA, LLC | $16.53 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135770184 | CMS |
| Lilly USA, LLC | $13.83 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135742120 | CMS |
| Lilly USA, LLC | $14.65 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135770186 | CMS |
| Novo Nordisk Inc | $20.42 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100502363 | CMS |
| Novo Nordisk Inc | $21.67 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100615473 | CMS |
| Novo Nordisk Inc | $19.09 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100286400 | CMS |
| Novo Nordisk Inc | $5.33 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100645369 | CMS |
| Novo Nordisk Inc | $17.10 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100352448 | CMS |
| Novo Nordisk Inc | $8.71 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100472105 | CMS |
| Novo Nordisk Inc | $14.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100392718 | CMS |
| Novo Nordisk Inc | $18.74 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100285510 | CMS |
| Novo Nordisk Inc | $3.22 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100290052 | CMS |
| Novo Nordisk Inc | $17.22 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100517795 | CMS |
| Novo Nordisk Inc | $2.74 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100592612 | CMS |
| Novo Nordisk Inc | $21.14 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100450527 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.24 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151160522 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.98 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151160524 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.